期刊文献+

CK19和PCNA在甲状腺良恶性乳头状增生上皮中的表达 被引量:2

Expression of CK 19 and PCNA in Benign and Malignant Epithelia of Papillary Hyperplasia of the Thytoid Gland
暂未订购
导出
摘要 目的 探讨细胞角蛋白19(CK19)和增殖细胞核抗原(PCNA)在甲状腺良恶性乳头状增生上皮中的表达与鉴别诊断中的作用。方法 应用免疫组化EnVision二步法对15例甲状腺恶性乳头状上皮及15例甲状腺良性乳头状上皮组织进行CK19及PCNA表达,以阳性细胞所占百分比作半定量计分的依据。结果 良恶性乳头状增生上皮AB项和的平均值经t检验显示差异具有显著性(P<0.01)。结论 联合应用CK19和PCNA,在区别甲状腺良恶性增生乳头上皮中的表达,准确率达95%以上,在鉴别诊断中有很大帮助。 Objective To study the expression of CK19 and PCNA in the benign and the malignant epithelia of papillary hyperplasia of the thytoid gland and their utility in the differential diagnosis. Methods The EnVision two-step im-munohistochemical stain was used to detect expression of CK 19 and PCNA in 15 cases of benign and malignant epithelia of papillary hyperplasia of the thyroid gland, respectively. The semi-quantitative score was counted according to the per-centage of the positive cells. Results The averages of the sums of two numbers (A + B) showed significant difference (P < 0.01) by t test between the benign and malignant groups. Conclusion Because of the combined use of CK19 and PCNA, the correct rate reached more than 95% in the benign and the malignant groups and it was helpful in differential diagnosis of thyroid lesions.
出处 《同济大学学报(医学版)》 CAS 2003年第6期478-479,489,共3页 Journal of Tongji University(Medical Science)
关键词 CK19 PCNA 甲状腺 良恶性乳头状增生 CK19 PCNA thyroid gland benign and malignant papilla hyperplasia
  • 相关文献

参考文献3

二级参考文献3

共引文献27

同被引文献28

  • 1中山医科大学、同济医科大学.外科病理学[M].第2版,武汉:湖北科学技术出版社,1998.1299-304.
  • 2Rapheal SL, Mckeown-Eyssen G, Asa SL. High molecular weight cytokeratin and cytokeratin 19 in the diagnosis of thyroid tumor[J].Mod Pathol, 1994, 7(1): 295-300.
  • 3Cameron BR, Berean KW. Cytokeratin subtypes in thyroid tumors:immunohistochemical study with emphasis on the follicular variant of papillary carcinoma[J]. J Otolaryngol, 2003, 32(5): 319-22.
  • 4Shin E, Chung WY, Yang WI, et al. RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation[J]. J Korean Med Sci, 2005, 20(1): 98-104.
  • 5Deleu S, Allory Y, Radulescu A, et al. Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology[J]. Thyroid, 2000, 10(2): 131-40.
  • 6Ros P, Rossi DL, Acebron A, et al. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis [J]. Biochimie,1999, 81(4): 389-96.
  • 7Kholova I, Ludvikova M, Ryska A, et al. Diagnostic role of markers dipeptidyl peptidase Ⅳ and thyroid peroxidase in thyroid tumors[J]. Anticancer Res, 2003, 23(2A): 871-5.
  • 8de Micco C, Kopp F, Vassko V, et al. In situ hybridization and immunohistochemistry study of thyroid peroxidase expression in thyroid tumors[J]. Thyroid, 2000, 10(2): 109-15.
  • 9Osada M,Ohba M,Kawahara C,et al.Cloning and functional analysis of human p51,which structurally and functionally resembles p53[J].Nat Med,1998,4(7):839~843
  • 10Quade BJ,Yang A,Wang Y,et al.Expression of the p53 homologue p63 in early cervical neoplasia[J].Gynecol oncol,2001,81(1):24~29

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部